Serum Bilirubin Levels with Antiepileptic Drugs

Epilepsia

Volumn 30, Issue 5, 1989, Pages 597-602

  Gough, H ^a   Goggin, T ^a   Crowley, M ^b   Callaghan, N ^a  

^a University College Cork and INFANT Centre   (Ireland)

^b UNIVERSITY COLLEGE CORK   (Ireland)

Author keywords

Anticonvulsants; Carbamazepine; Drug induced abnormalities; Epilepsy; Phenobarbital; Phenytoin; Valproate

Indexed keywords

BILIRUBIN; CARBAMAZEPINE; PHENOBARBITAL; PHENYTOIN; VALPROIC ACID;

ADOLESCENT; ADULT; BLOOD LEVEL; EPILEPSY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

ADULT; BILIRUBIN; CARBAMAZEPINE; CHROMATOGRAPHY, GAS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; COHORT STUDIES; COMPARATIVE STUDY; DRUG COMBINATIONS; EPILEPSY; FEMALE; HUMAN; MALE; PHENOBARBITAL; PHENYTOIN; SUPPORT, NON-U.S. GOV'T; VALPROIC ACID;

EID: 0024424026     PISSN: 00139580     EISSN: 15281167     Source Type: Journal    
DOI: 10.1111/j.1528-1157.1989.tb05478.x     Document Type: Article

References (21)

1. Abnormalities in liver function tests during long‐term diphenylhydantoin therapy in epileptic out‐patients
2. Treatment of Gilbert's syndrome with phe‐nobarbitone
3. A simple method for the determination of epilim in serum
4. Pharmacological implications of microsomal enzyme induction
5. Chronic toxicity in epileptic patients receiving single drug treatment
6. Recent advances in bilirubin formation, transport, metabolism and excretion
7. Clinical and electroencephalographic classification of epileptic seizures
8. A comparative study of the relative influence of different anticonvulsant drugs, UV exposure and diet on vitamin D and calcium metabolism in out‐patients with epilepsy
9. Hepatotoxic reactions associated with carbamazepine therapy
10. Hepatotoxicity of antiepileptic drugs
11. Simultaneous measurement of phenobarbital, phenytoin, primidone, etho‐suximide and carbamazepine in serum by high performance liquid chromatography
12. Elevated serum alkaline phosphatase levels in epilepsy during diphenylhydantoin therapy
13. Studies in the mechanism of phenobarbi‐tal‐enhanced sulfobromopthalein disappearance
14. Biochemical evidence for osteomalacia with carbamazepine therapy
15. Adverse haematological effects of antiepileptic drugs
16. Disturbance of calcium metabolism by anticonvulsant drugs
17. Rapid micromethod for measuring anticonvulsant drugs in serum by high performance liquid chromatography
18. Bilirubin metabolism
19. Low plasma bilirubin in epileptics on phenobarbitone
20. Enhancement of glucuronide‐conjugating capacity in a hyperbilinibuiemic infant due to apparent enzyme induction by phenobarbital
21. Phenobarbitone prophylaxis for neonatal hyperbilirubinaemia